Literature DB >> 3548485

Meperidine as a spinal anesthetic agent: a comparison with lidocaine-glucose.

S Sangarlangkarn, V Klaewtanong, P Jonglerttrakool, V Khankaew.   

Abstract

The anesthetic effect of 2 ml of 5% lidocaine in 7.5% glucose (LG) or 5% meperidine in water were evaluated and compared in 40 ASA class 1 or 2 patients. Patients were randomly assigned to one of the two groups (20 patients in each) according to the anesthetic agent, which was injected into the lumbar subarachnoid space in the sitting position. The patients remained sitting for 5 min before being placed in the supine position. Times of onset of sensory and complete motor blockade were significantly more rapid with LG. The extent of maximum cephalad spread of analgesia and the time to maximum height of analgesia in the two groups were not different. Duration of analgesia at the T-7 (48.96 +/- 6.64 min with LG, 44.74 +/- 6.14 min with meperidine; means +/- SEM) and L-1 (94.37 +/- 7.42 min with LG, 76.19 +/- 5.64 min with meperidine) dermatomes was not different in the two groups but was statistically longer at the T-10 dermatome with LG (66.83 +/- 6.72 min) than with meperidine (46.66 +/- 6.26 min). The duration of complete motor blockade was also significantly longer with LG (66.44 +/- 7.05 min) than with meperidine (42.67 +/- 4.47 min). Complications in both groups included decrease in blood pressure and nausea and vomiting intraoperatively, and urinary retention, nausea and vomiting, and mild headache postoperatively. Complications that occurred only in the meperidine group were intraoperative drowsiness, respiratory depression, bronchospasm, and itching. The frequency of complications was greater wit meperidine.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3548485

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  13 in total

1.  Low-dose intrathecal-meperidine for lower limb orthopaedic surgery.

Authors:  S Kavuri; J Robalino; Y Janardhan; K Shevde
Journal:  Can J Anaesth       Date:  1990-11       Impact factor: 5.063

2.  A comparison of the haemodynamic effects of intrathecal meperidine, meperidine-bupivacaine mixture and hyperbaric bupivacaine.

Authors:  F Conway; L A Critchley; J C Stuart; R C Freebairn
Journal:  Can J Anaesth       Date:  1996-01       Impact factor: 5.063

3.  Comparison of intrathecal meperidine and lidocaine in endoscopic urological procedures.

Authors:  D Patel; Y Janardhan; B Merai; J Robalino; K Shevde
Journal:  Can J Anaesth       Date:  1990-07       Impact factor: 5.063

4.  Treatment with isoproterenol of bupivacaine toxicity.

Authors:  P Lacombe; G Blaise; F Plante; C Hollmann
Journal:  Can J Anaesth       Date:  1990-05       Impact factor: 5.063

5.  Severe hypotension from epidural meperidine in a high-risk patient after thoracotomy.

Authors:  M Balaban; P Slinger
Journal:  Can J Anaesth       Date:  1989-07       Impact factor: 5.063

6.  Bronchospasm induced with ergometrine during high spinal anesthesia.

Authors:  Yoshihiro Hirabayashi; Hirokazu Fukuda; Kazuhiko Saitoh; Reiju Shimizu
Journal:  J Anesth       Date:  1995-06       Impact factor: 2.078

Review 7.  Recent developments in analgesia during labour.

Authors:  R E Kan; S C Hughes
Journal:  Drugs       Date:  1995-09       Impact factor: 9.546

8.  Clinical and pharmacokinetic aspects of the combination of meperidine and prilocaine for spinal anaesthesia.

Authors:  P Tauzin-Fin; P Maurette; G Vincon; D Hecquet; M C Houdek; F Bonnet
Journal:  Can J Anaesth       Date:  1992-09       Impact factor: 5.063

9.  Respiratory depression associated with meperidine spinal anaesthesia.

Authors:  B Ong; R Segstro
Journal:  Can J Anaesth       Date:  1994-08       Impact factor: 5.063

10.  Intraperitoneal pethidine versus intramuscular pethidine for the relief of pain after laparoscopic cholecystectomy: randomized trial.

Authors:  Deirdre M O'Hanlon; Sallyann Colbert; Jackie Ragheb; Gerry P McEntee; Frank Chambers; D C Moriarty
Journal:  World J Surg       Date:  2002-10-10       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.